Adherence to hepatitis B vaccine doses in healthy transgender women (TGW) Not Applicable
Conditions
Interventions
The study included 230 TGW who reported no previous hepatitis B or were unaware of their hepatitis B vaccination status in a hepatitis B vaccination cohort. They were randomly recruited to receive eit
four doses at 0, 7, 21, and 180 days) or a standard scheme (G2
three doses at 0, 1, and 4 months). Vaccine doses of 20 µg of recombinant HBsAg were administered into the deltoid muscle (Serum Institute of India PVT. LTD
lots 03560L24 and 03560L72).
Sponsors
Fundação de Amparo a Pesquisa do Estado de Goiás
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Self-defined as transgender women 2. Present valid RDS coupon 3. Report no hepatitis B vaccine doses previously or don't know her vaccine status
Exclusion criteria
Exclusion criteria: Persons who were found noticeably under the effects of psychoactive drugs (drunken and dopey) were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence to at least three vaccine doses measured using patient records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Immunogenicity of hepatitis B vaccine measured using anti-HBs titer measure following the third and fourth vaccine doses. | — |
Countries
Brazil
Outcome results
None listed